Jeffrey H. Newcorn, M.D.
Icahn School of Medicine at Mount Sinai
Psychiatry
One Gustave L. Levy Place
Bos 1230
New York,
NY
USA
10029
Papers:
19
Real-World Applications of New ADHD Clinical Trials
36
The Interface of Impulsivity and Emotional Control: New Insights on Mechanism and Treatment
2.30
The Atomoxetine-Stimulant Side Effects Rating Scale: Factor Structure and Associated Clinical Characteristics for OROS Methylphenidate and Atomoxetine
4.57
Risk for Emerging Bipolar Disorder, Bipolar Variants, and Symptoms in Children with ADHD, Now Grown Up
16.3
Preferential Effects of Metadoxine Extended-Release on Inattentive Subtype ADHD
19.1
Comparative Effectiveness of Methylphenidate and Atomoxetine in Youth with ADHD: Results of a Randomized, Two-Site Crossover Study
19.2
Side Effects of ADHD Medications During Two Crossover Studies